Concepts (108)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tumor Microenvironment | 2 | 2026 | 203 | 1.000 |
Why?
|
| Triple Negative Breast Neoplasms | 1 | 2025 | 36 | 0.870 |
Why?
|
| Boron Neutron Capture Therapy | 1 | 2023 | 1 | 0.800 |
Why?
|
| Breast Neoplasms | 2 | 2026 | 484 | 0.760 |
Why?
|
| Biomarkers, Tumor | 1 | 2026 | 415 | 0.760 |
Why?
|
| Radiosurgery | 2 | 2020 | 84 | 0.740 |
Why?
|
| Brain Neoplasms | 2 | 2021 | 313 | 0.640 |
Why?
|
| Cone-Beam Computed Tomography | 1 | 2020 | 41 | 0.620 |
Why?
|
| Radiotherapy Planning, Computer-Assisted | 1 | 2020 | 69 | 0.610 |
Why?
|
| Apoptosis | 5 | 2014 | 781 | 0.570 |
Why?
|
| Hepatocyte Growth Factor | 1 | 2014 | 6 | 0.440 |
Why?
|
| Genomic Instability | 1 | 2014 | 34 | 0.430 |
Why?
|
| Transcriptional Activation | 1 | 2014 | 86 | 0.430 |
Why?
|
| Neoplasms | 1 | 2023 | 882 | 0.410 |
Why?
|
| Colonic Neoplasms | 1 | 2014 | 122 | 0.390 |
Why?
|
| Adenocarcinoma | 1 | 2014 | 301 | 0.350 |
Why?
|
| Gene Expression Profiling | 2 | 2026 | 477 | 0.300 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2026 | 472 | 0.280 |
Why?
|
| Gastrointestinal Stromal Tumors | 3 | 2014 | 12 | 0.280 |
Why?
|
| Humans | 12 | 2026 | 29078 | 0.260 |
Why?
|
| Female | 6 | 2026 | 15740 | 0.250 |
Why?
|
| Middle Aged | 4 | 2026 | 7458 | 0.240 |
Why?
|
| Gene Regulatory Networks | 1 | 2026 | 82 | 0.240 |
Why?
|
| Proto-Oncogene Proteins c-met | 2 | 2014 | 13 | 0.210 |
Why?
|
| Aged, 80 and over | 3 | 2020 | 2070 | 0.210 |
Why?
|
| Transcriptome | 1 | 2026 | 243 | 0.210 |
Why?
|
| Boron | 1 | 2023 | 1 | 0.200 |
Why?
|
| Boron Compounds | 1 | 2023 | 5 | 0.200 |
Why?
|
| Radiobiology | 1 | 2023 | 5 | 0.200 |
Why?
|
| Mastectomy | 1 | 2021 | 22 | 0.170 |
Why?
|
| Nanotechnology | 1 | 2021 | 68 | 0.170 |
Why?
|
| Nanomedicine | 1 | 2021 | 62 | 0.170 |
Why?
|
| Glioblastoma | 1 | 2021 | 109 | 0.160 |
Why?
|
| Artifacts | 1 | 2020 | 51 | 0.150 |
Why?
|
| Aged | 3 | 2020 | 5627 | 0.150 |
Why?
|
| Databases, Factual | 1 | 2019 | 271 | 0.140 |
Why?
|
| Nanoparticles | 1 | 2021 | 292 | 0.130 |
Why?
|
| Prognosis | 2 | 2019 | 815 | 0.120 |
Why?
|
| Prostatic Neoplasms | 1 | 2019 | 304 | 0.120 |
Why?
|
| Antineoplastic Agents | 2 | 2014 | 686 | 0.120 |
Why?
|
| Animals | 4 | 2025 | 10756 | 0.120 |
Why?
|
| Autocrine Communication | 1 | 2014 | 7 | 0.110 |
Why?
|
| HT29 Cells | 1 | 2014 | 20 | 0.110 |
Why?
|
| Microsatellite Instability | 1 | 2014 | 11 | 0.110 |
Why?
|
| DNA Mismatch Repair | 1 | 2014 | 13 | 0.110 |
Why?
|
| HCT116 Cells | 1 | 2014 | 54 | 0.110 |
Why?
|
| Receptor-Interacting Protein Serine-Threonine Kinases | 1 | 2014 | 25 | 0.110 |
Why?
|
| Necrosis | 1 | 2014 | 85 | 0.110 |
Why?
|
| Caspase 3 | 1 | 2014 | 58 | 0.110 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2014 | 194 | 0.100 |
Why?
|
| Transfection | 1 | 2014 | 319 | 0.100 |
Why?
|
| Male | 3 | 2020 | 14049 | 0.100 |
Why?
|
| Kv Channel-Interacting Proteins | 1 | 2013 | 1 | 0.100 |
Why?
|
| Hepatocytes | 1 | 2014 | 96 | 0.100 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 2014 | 41 | 0.100 |
Why?
|
| Benzamides | 1 | 2013 | 40 | 0.100 |
Why?
|
| Promoter Regions, Genetic | 1 | 2014 | 344 | 0.100 |
Why?
|
| Cell Survival | 1 | 2014 | 420 | 0.100 |
Why?
|
| Piperazines | 1 | 2013 | 50 | 0.100 |
Why?
|
| Repressor Proteins | 1 | 2013 | 120 | 0.090 |
Why?
|
| Pyrimidines | 1 | 2013 | 128 | 0.090 |
Why?
|
| Phenotype | 1 | 2014 | 688 | 0.090 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2014 | 681 | 0.090 |
Why?
|
| Cell Proliferation | 1 | 2014 | 827 | 0.090 |
Why?
|
| Adult | 2 | 2020 | 8080 | 0.080 |
Why?
|
| Time Factors | 1 | 2014 | 1619 | 0.080 |
Why?
|
| Signal Transduction | 2 | 2014 | 1482 | 0.080 |
Why?
|
| Boronic Acids | 1 | 2009 | 9 | 0.080 |
Why?
|
| Pyrazines | 1 | 2009 | 26 | 0.080 |
Why?
|
| Retrospective Studies | 2 | 2021 | 2651 | 0.050 |
Why?
|
| Radiation-Sensitizing Agents | 1 | 2021 | 33 | 0.040 |
Why?
|
| Florida | 1 | 2021 | 55 | 0.040 |
Why?
|
| Models, Animal | 1 | 2021 | 130 | 0.040 |
Why?
|
| Stem Cells | 1 | 2021 | 123 | 0.040 |
Why?
|
| Drug Carriers | 1 | 2021 | 119 | 0.040 |
Why?
|
| Anxiety | 1 | 2021 | 162 | 0.040 |
Why?
|
| Drug Delivery Systems | 1 | 2021 | 236 | 0.040 |
Why?
|
| Stress, Psychological | 1 | 2021 | 234 | 0.040 |
Why?
|
| Cell Line, Tumor | 2 | 2013 | 1360 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2019 | 1033 | 0.030 |
Why?
|
| Quality of Life | 1 | 2021 | 523 | 0.030 |
Why?
|
| Caspase Inhibitors | 1 | 2014 | 8 | 0.030 |
Why?
|
| Cytoprotection | 1 | 2014 | 24 | 0.030 |
Why?
|
| Mice | 2 | 2014 | 4845 | 0.030 |
Why?
|
| Mitoxantrone | 1 | 2014 | 2 | 0.030 |
Why?
|
| Topoisomerase II Inhibitors | 1 | 2014 | 5 | 0.030 |
Why?
|
| Plicamycin | 1 | 2014 | 4 | 0.030 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2014 | 103 | 0.030 |
Why?
|
| Protein Structure, Tertiary | 1 | 2014 | 284 | 0.030 |
Why?
|
| Oligopeptides | 1 | 2014 | 97 | 0.020 |
Why?
|
| Imatinib Mesylate | 1 | 2013 | 15 | 0.020 |
Why?
|
| Tumor Cells, Cultured | 1 | 2014 | 314 | 0.020 |
Why?
|
| Binding Sites | 1 | 2014 | 355 | 0.020 |
Why?
|
| Cell Death | 1 | 2013 | 119 | 0.020 |
Why?
|
| Mice, Nude | 1 | 2014 | 333 | 0.020 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2013 | 97 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2014 | 697 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2014 | 1057 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2014 | 405 | 0.020 |
Why?
|
| Molecular Targeted Therapy | 1 | 2013 | 137 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2009 | 12 | 0.020 |
Why?
|
| Bortezomib | 1 | 2009 | 23 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2009 | 114 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2009 | 68 | 0.020 |
Why?
|
| Histones | 1 | 2009 | 96 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2009 | 329 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2009 | 292 | 0.020 |
Why?
|
| Gene Expression | 1 | 2009 | 417 | 0.020 |
Why?
|